Are you preparing to return to your lab, or are you in the middle of figuring out how to scale up your workflow? It is no question that researchers returning to the lab are facing challenges unlike ever before, as they navigate a new research landscape that continues being shaped by the COVID-19 pandemic. Staying connected to your team, keeping up with new safety protocols, and managing uncertainty about your funding are just a few of the many challenges you are now having to overcome.
Join us for a virtual panel where we’ll discuss how to manage these challenges in more depth. We’re sitting down with a panel of accomplished researchers to hear how they’re planning to navigate the post COVID-19 research landscape, and their strategies for turning this global crisis into an opportunity for positive change and innovation in the scientific world. You’ll walk away with ideas on how to successfully overcome the many challenges presented by the pandemic, and learn how to stay at the forefront of change.
Chief Scientific Officer, Biopharma & VP, Protein Engineering
Aaron is the Chief Scientific Officer of the Biopharma Vertical at Twist Bioscience. Prior to Twist, he served as Chief Scientific Officer of LakePharma, leading the California Antibody Center, which discovers novel antibody therapeutics for its clients. He also oversaw all discovery research functions both as Vice President of Protein Sciences at Surrozen, and previously, as Vice President of Research at Sutro Biopharma, Inc. He also held director level positions at both Oncomed and Dyax Corp.
Tonya is an Associate Professor at the East Carolina University Brody School of Medicine. Her research interests lie in untangling the complex mechanism of aberrant enzyme activity, specifically in the context of metabolic disorders and neurodegenerative diseases. Her lab uses techniques common to the fields of molecular biology, chemical biology and enzymology, such as protein engineering, site-directed mutagenesis, steady-state and pre-steady-state kinetics, and organic synthesis.
Assistant Professor & Principle Investigator
Dr. Gage is an Associate Professor in the Chemistry Department at the University of Massachusetts Lowell. His research interests lie in protein-protein interactions, specifically interactions involving muscle proteins. Recently, his team has been looking at interactions between peptides derived from the SARS-CoV-2 virus and anti-CoV-2 antibodies.
Associate Professor & Associate Chair, Graduate Studies and Research
Dr. Dieckmann is an Associate Professor & Associate Chair, Graduate Studies and Research in the Chemistry Department at the University of Waterloo. His research interests include the biophysics of RNA, structure and function of RNA and proteins, high resolution NMR spectroscopy, catalysis, drug design, viral infections, RNA world and the origin of life.